These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5311321)

  • 1. Species and sex differences in the substrate-induced spectral change of P-450 in relation to the activity of drug oxidation in liver microsomes.
    Kato R; Onoda K; Takayanagi M
    Jpn J Pharmacol; 1970 Mar; 20(1):157-63. PubMed ID: 5311321
    [No Abstract]   [Full Text] [Related]  

  • 2. Species differences in the effect of morphine administration or adrenalectomy on the substrate interactions with cytochrome P-450 and drug oxidations by liver microsomes.
    Kato R; Onoda KI; Takanaka A
    Biochem Pharmacol; 1971 Jun; 20(6):1093-9. PubMed ID: 5118111
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Onoda K; Sasajima M
    Jpn J Pharmacol; 1970 Jun; 20(2):194-209. PubMed ID: 4393947
    [No Abstract]   [Full Text] [Related]  

  • 4. Substrate-induced spectral change of liver microsomes in phenobarbital and methylcholanthrene-treated male and female rats.
    Kato R; Takanaka A; Takayanaghi M
    J Biochem; 1970 Sep; 68(3):395-413. PubMed ID: 5472352
    [No Abstract]   [Full Text] [Related]  

  • 5. Species difference in drug metabolism by liver microsomes in alloxan diabetic or fasted animals. II. The substrate interaction with cytochrome P-450 in drug oxidation.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):554-61. PubMed ID: 5312937
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of thyroid hormone on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Takahashi A
    J Biochem; 1970 Nov; 68(5):613-23. PubMed ID: 5484443
    [No Abstract]   [Full Text] [Related]  

  • 7. The nature of the reverse type I (modified type II) spectral change in liver microsomes.
    Schenkman JB; Cinti DL; Orrenius S; Moldeus P; Kraschnitz R
    Biochemistry; 1972 Nov; 11(23):4243-51. PubMed ID: 5079897
    [No Abstract]   [Full Text] [Related]  

  • 8. Strain differences in the metabolism and action of drugs in mice and rats.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):562-71. PubMed ID: 5312938
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of aniline and hexobarbital by liver homogenates of spironolactone-pretreated male rats.
    Talcott RE; Stohs SJ
    J Pharm Sci; 1972 Feb; 61(2):296-7. PubMed ID: 5059808
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of starvation on the kinetics of drug oxidation by hepatic microsomal enzymes from male and female rats.
    Gram TE; Guarino AM; Schroeder DH; Davis DC; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):12-21. PubMed ID: 5471443
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Onoda K
    Biochem Pharmacol; 1971 Feb; 20(2):447-58. PubMed ID: 5150143
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mechanism of sex difference in drug-oxidizing activity of liver microsomes.
    Kato R; Takanaka A; Takayanagi M
    Jpn J Pharmacol; 1968 Dec; 18(4):482-9. PubMed ID: 4388258
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of malathion on hepatic microsomal metabolism of the male mouse.
    Stevens JT
    Pharmacology; 1974; 11(6):330-5. PubMed ID: 4413070
    [No Abstract]   [Full Text] [Related]  

  • 14. Species difference in the inhibition of drug metabolism by liver microsomes by different inhibitors.
    Kato R; Onoda K; Takayanagi M
    Jpn J Pharmacol; 1969 Sep; 19(3):438-50. PubMed ID: 4390624
    [No Abstract]   [Full Text] [Related]  

  • 15. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human liver microsomal drug metabolism.
    Darby FJ; Newnes W; Price Evans DA
    Biochem Pharmacol; 1970 Apr; 19(4):1514-7. PubMed ID: 4398013
    [No Abstract]   [Full Text] [Related]  

  • 17. Species differences and drug metabolism.
    Flynn EJ; Lynch M; Zannoni VG
    Biochem Pharmacol; 1972 Oct; 21(19):2577-90. PubMed ID: 4145289
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of cyproterone acetate pretreatment on the in vitro metabolism of aniline, hexobarbital and 3 H-digitoxigenin.
    Talcott RE; Stohs SJ
    J Pharmacol Exp Ther; 1973 Feb; 184(2):419-23. PubMed ID: 4688178
    [No Abstract]   [Full Text] [Related]  

  • 19. Species difference in drug metabolism by liver microsomes in alloxan diabetic or fasted animals. I. The activity of drug-metabolizing enzymes and electron transport system.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):546-53. PubMed ID: 5312936
    [No Abstract]   [Full Text] [Related]  

  • 20. Diphenylhydantoin effects on hexobarbital and aniline biotransformation in male rats: differences between in vitro and in vivo observations.
    Gut I; Becker BA
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):253-8. PubMed ID: 1209623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.